WO2025149998 - TOPICAL COMPOSITION COMPRISING CLASCOTERONE AND LATANOPROST FOR ALOPECIA
National phase entry is expected:
Publication Number
WO/2025/149998
Publication Date
17.07.2025
International Application No.
PCT/IB2025/050381
International Filing Date
13.01.2025
Title **
[English]
TOPICAL COMPOSITION COMPRISING CLASCOTERONE AND LATANOPROST FOR ALOPECIA
[French]
COMPOSITION TOPIQUE COMPRENANT DE LA CLASCOTÉRONE ET DU LATANOPROST POUR L'ALOPÉCIE
Applicants **
GLENMARK SPECIALTY S.A.
Inventors
OTAVKAR, Roopali
ABRAHAM, Jaya
BANGAR, Ganesh
DHUPPAD, Ulhas
KULKARNI, Abhay
GANDHI, Maulik
UDUPA, Venkatesh
PAWAR, Pramod
CHOPADE, Atul
Priority Data
202421002308
11.01.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2227 | |
| EPO | Filing, Examination, Granting | 11685 | |
| Japan | Filing, Examination, Granting | 2368 | |
| South Korea | Filing, Examination, Granting | 2511 | |
| USA | Filing, Examination, Granting | 5140 |
Total:
23,931
Contact Us
Abstract[English]
The present invention relates to the topical pharmaceutical composition comprising about 0.001% w/w to about 1% w/w latanoprost and about 1% w/w to about 15% w/w cortexolone-17α-propionate and a pharmaceutically acceptable vehicle comprising one or more solvent and process of its preparation. The invention further relates to the method wherein the composition is suitable for preventing and/or treating hair loss and/or stimulating hair growth. in patients suffering from alopecia, in particular androgenic alopecia (AGA).[French]
La présente invention concerne la composition pharmaceutique topique comprenant environ 0,001 % p/p à environ 1 % p/p de latanoprost et environ 1 % p/p à environ 15 % p/p de cortexolone-17α-propionate et un véhicule pharmaceutiquement acceptable comprenant un ou plusieurs solvants et un procédé pour sa préparation. L'invention concerne en outre le procédé selon lequel la composition est appropriée pour prévenir et/ou traiter la chute des cheveux et/ou stimuler la pousse des cheveux chez les patients atteints d'alopécie, en particulier l'alopécie androgénique (AGA).